Dr. Rodolfo Maldonado, MD

Dr. Maldonado practices at Rodolfo Maldonado MD in Perth Amboy, New Jersey.

Dr. Maldonado's NPI, 1093823668, was assigned on August 25, 2006. Dr. Maldonado holds New Jersey license 25MA07792000.

Dr. Maldonado's primary practice is Rodolfo Maldonado MD, at 86 New Brunswick Ave, Perth Amboy, NJ 08861 in Middlesex County. The practice phone is (732) 826-2220.

Dr. Maldonado's primary practice is Rodolfo Maldonado MD in Perth Amboy, New Jersey. Dr. Maldonado is also affiliated with Raritan Bay Medical Center. The medical group on file is Rodolfo Maldonado MD LLC. Dmand AI also links Dr. Maldonado to 1 more hospital, 2 skilled nursing facilities, 1 group practice or clinic, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maldonado practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Maldonado's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Maldonado is licensed in New Jersey.

CMS data shows 2,254 Medicare services from Dr. Maldonado across 22 procedure codes in 2024, for 345 Medicare patients. Medicare paid $180,788 for them.

CMS counts 345 Medicare patients who saw Dr. Maldonado in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 50% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maldonado's median patient age at 65, with 58% women.

In 2024, Dr. Maldonado wrote 13,371 Medicare Part D claims for 778 patients. 84% of them were for generic drugs. CMS names the drug for 12,340 of them, across 189 drugs with 11 or more claims each, at $965,318 in total drug cost. In 2023, CMS named 11,813 claims across 187 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 39 out of 100 for Dr. Maldonado for performance year 2024, reported individually. Dr. Maldonado accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maldonado as offering telehealth.

CMS Open Payments shows 72 general payments to Dr. Maldonado from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novo Nordisk Inc paid the most, $415.